強
強気
強気 · 25%DNA
$11.62
シナリオ価格
$10.010
+0.152 (+1.52%)終値時点
Loading chart…
- 高値
- 10.100
- 始値
- 9.880
- 出来高加重平均価格
- 9.91
- 出来高
- 1.78M
- 時価総額
- 683.73M
- 安値
- 9.612
- 売買代金
- 17.61M
- EV/EBITDA（TTM）
- -4.45
Ginkgo Bioworks Holdings, Inc. offers biological research and development (R&D) services on its platform and autonomous laboratory to enable its customers to bring their products to market. The Company sells tools and biological R&D services across a range of industries to government and commercial customers. Its in-house autonomous lab is available as Cloud Lab through its Datapoints and Solutions contract research services. Its single segment, namely cell engineering, provides tools and biological R&D services across a range of industries. Its cell engineering customers work with biology to discover and manufacture new products across industries such as medicine, agriculture, industrial biotechnology and government. It provides R&D services spanning genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics. It provides a suite of microservices for product developers across industries that support bioengineers with protein engineering.
AI分析 of Ginkgo Bioworks Holdings Inc (DNA)
売りGinkgo Bioworks is not a good buy right now due to its significant financial struggles and negative market sentiment. The current price is $10.27, and the company reported a staggering 21% decline over the last five days. Additionally, the RSI is at 35.487, indicating oversold conditions but also reflecting weak momentum. The recent downgrade by TD Cowen, coupled with insider selling increasing by 74248.78%, suggests a lack of confidence in the company's near-term growth prospects, making it a risky investment at this time.
アナリスト評価（2）
上値余地 +19.88%
売り
0 買い
0 中立
2 売り
現在: 10.01
安値
12.00
平均
12.00
高値
12.00
TD Cowen
中立
$9
2026-08-07
TD Cowen
2026-08-07
目標株価
$9
中立
BTIG
売り
$5
2026-03-12
BTIG
2026-03-12
目標株価
$5
売り
TD Cowen
買い
$12
2026-01-08
TD Cowen
2026-01-08
目標株価
$12
買い
BTIG
売り
$9
2025-08-25
BTIG
2025-08-25
目標株価
$9
売り
TD Cowen
買い
$16
2025-08-08
TD Cowen
2025-08-08
目標株価
$16
買い
バリュエーション指標
Ginkgo Bioworks Holdings Inc（DNA）の現在の予想PERは0.00で、5年平均は-6.47です。
Alphio AI による DNA の価格シナリオ
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト（25 / 50 / 25）であり、保証ではありません。
DNA を保有するクジラ
イベントタイムライン
ニュース
7.510-09PRnewswireGinkgo Integrates Araceli's High-Throughput Imaging Technology
7.510-08NewsfilterGinkgo Bioworks Supports NSF X-Labs Program with Autonomous Lab Access
7.510-08PRnewswireGinkgo Bioworks Integrates Araceli's High-Throughput Imaging Technology
7.510-08PRnewswireAraceli and Ginkgo Enhance Cellular Imaging Capabilities
7.510-08PRnewswireGinkgo Integrates Araceli's Endeavor for Enhanced Cellular Data Generation
DNA のよくある質問 — Alphio AI が回答
Ginkgo Bioworks Holdings, Inc. offers biological research and development (R&D) services on its platform and autonomous laboratory to enable its customers to bring their products to market. The Company sells tools and biological R&D services across a range of industries to government and commercial customers. Its in-house autonomous lab is available as Cloud Lab through its Datapoints and Solutions contract research services. Its single segment, namely cell engineering, provides tools and biological R&D services across a range of industries. Its cell engineering customers work with biology to discover and manufacture new products across industries such as medicine, agriculture, industrial biotechnology and government. It provides R&D services spanning genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics. It provides a suite of microservices for product developers across industries that support bioengineers with protein engineering. It operates in the Healthcare sector (BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry).
Ginkgo Bioworks is not a good buy right now due to its significant financial struggles and negative market sentiment. The current price is $10.27, and the company reported a staggering 21% decline over the last five days. Additionally, the RSI is at 35.487, indicating oversold conditions but also reflecting weak momentum. The recent downgrade by TD Cowen, coupled with insider selling increasing by 74248.78%, suggests a lack of confidence in the company's near-term growth prospects, making it a risky investment at this time.
2 analysts cover DNA: 0 rate it Buy, 0 Hold and 2 Sell. The average price target is 12.00.
コミュニティ
もっと見る ↗
$DNA DUMPS 27% | BEARISH TARGET IN SIGHT My October 19 bearish setup on #DNA continues to play out, with price now down to $0.19074, a ~27% drop from our short setup's breakdown exit point. Updated Technical Analysis: ➤ Current Price: $0.19074 ➤ Bearish Target: $0.148 ➤ Key Resistance: $0.250 ➤ Bearish Outlook: Still watching for further downside toward $0.148. The chart is doing the talking. Hope you're enjoying the analysis. Stay tuned for the next update.
もっと見る
Gate Futures Listings | October 12–18, 2026 One-stop access to popular memes, crypto assets, stocks, and ETFs. 🔹 New: 14 futures trading pairs. As of now, Gate supports trading 482+ stock futures. 🔹 Last week's highlights: $DNA, $BATON, $CLAUDIA, $SBUX, and other futures tokens. 🔹 Long and short positions support up to 20x leverage, helping you respond flexibly to market conditions. 🔹 Join popular futures events to earn more rewards. Stock Futures Bonus Season: Share a 500,000 USDT prize pool, with up to 1,000 USDT per person. ChangXin Memory and Unitree Robotics futures trading competition: register to receive 5 USDT, with up to 240 USDT per person.
もっと見る
Successful investing is about more than chasing profits; it requires knowledge, patience, strategic planning, and a clear understanding of risk. Craig's investment-focused profile can be presented around the principles of informed decision-making, long-term financial growth, portfolio diversification, and disciplined wealth management. Building wealth takes a thoughtful approach. Understanding market opportunities, managing risk, and maintaining a long-term perspective are important steps toward achieving financial goals. Invest with knowledge. Manage risk with discipline. Build wealth with a vision for the future. $DNA $PHA $XRP
もっと見る
I'm down bad, guys. I trusted you so much, $DNA. Holding to the end—go ahead and take it to zero if you can.
もっと見る本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。